Journal of Cardiac Failure

Journal

Publication Venue For

  • Non-Concordance between Patient and Clinician Estimates of Prognosis in Advanced Heart Failure: Prognostic Estimates in Advanced HF.  27:700-705. 2021
  • The Dietary Approaches to Stop Hypertension (DASH) Diet Pattern and Incident Heart Failure.  27:512-521. 2021
  • An Interprofessional Collaborative Practice Can Reduce Heart Failure Hospital Readmissions and Costs in an Underserved Population 2021
  • Mid- to Late-Life Inflammation and Risk of Cardiac Dysfunction, HFpEF and HFrEF in Late Life 2021
  • Right Ventricular Ejection Fraction and Beta-Blocker Effect in Heart Failure With Reduced Ejection Fraction 2021
  • Diagnostic And Prognostic Implications of Heart Failure With Preserved Ejection Fraction Scoring Systems.  26:S38-S38. 2020
  • Low Utilization of Beta-Blockers Among Medicare Beneficiaries Hospitalized for Heart Failure With Reduced Ejection Fraction.  25:343-351. 2019
  • The Prevalence of Cognitive Impairment Among Adults With Incident Heart Failure: The “Reasons for Geographic and Racial Differences in Stroke” (REGARDS) Study.  25:130-136. 2019
  • Resting Heart Rate and Chronotropic Response to Exercise: Prognostic Implications in Heart Failure Across the Left Ventricular Ejection Fraction Spectrum.  24:753-762. 2018
  • Acute Hemodynamic Effects of Biventricular Pacing After Left Ventricular Assist Device.  24:716-718. 2018
  • High Right Atrial Pressure and Low Pulse Pressure Predict Gastrointestinal Bleeding in Patients With Left Ventricular Assist Device.  24:487-493. 2018
  • Psychosocial Factors Related to Adverse Outcomes in Caregivers of Heart Failure Patients: A Structural Equation Modeling Analysis.  24:S101-S101. 2018
  • Mind-Body Interventions for Individuals With Heart Failure: A Systematic Review of Randomized Trials.  24:186-201. 2018
  • Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes.  23:887-899. 2017
  • Mind-body interventions for individuals with heart failure: A systematic review of randomized trials.  24:186-201. 2017
  • Deactivation of Left Ventricular Assist Devices: Differing Perspectives of Cardiology and Hospice/Palliative Medicine Clinicians.  23:708-712. 2017
  • Problems Experienced by Heart Failure Patients the First Month After Discharge from a Heart Failure Related Hospitalization.  23:S86-S86. 2017
  • Deactivation of Ventricular Assist Devices: Perspectives and Experiences of Adult Cardiovascular Providers.  23:485-486. 2017
  • Corrigendum to Abstract 389 "Identification of Educational Gaps Amongst Physicians Who Manage Patients with Chronic Heart Failure": Journal of Cardiac Failure, Vol. 22, No. 8S, August 2016, p. S135..  23:93. 2017
  • Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITAS.  22:815-822. 2016
  • Conflicting Perceptions of Prognosis and Treatment Options between Physicians and Patients with Advanced Heart Failure: Results From the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry.  22:S18-S18. 2016
  • Characteristics and In-Hospital Outcomes of Peripartum Cardiomyopathy Diagnosed During Delivery in the United States From the Nationwide Inpatient Sample (NIS) Database.  22:512-519. 2016
  • Acute heart failure in the elderly: Differences in clinical characteristics, outcomes, and prognostic factors in the Veritas study.  21:179-188. 2015
  • Heart failure and respiratory hospitalizations are reduced in patients with heart failure and chronic obstructive pulmonary disease with the use of an implantable pulmonary artery pressure monitoring device.  21:240-249. 2015
  • Hemodynamic ranges during daily activities and exercise testing in patients with pulmonary arterial hypertension.  20:485-491. 2014
  • Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, Dyssynchrony, and contractile function in patients with New York heart association functional class I/II heart failure: MADIT-CRT.  19:149-155. 2013
  • Palliative care consultations for heart failure patients: How many, when, and why?.  19:193-201. 2013
  • Heart failure is a risk factor for incident driving cessation among community-dwelling older adults: Findings from a prospective population study.  17:1035-1040. 2011
  • Systemic oxidative stress and endothelial dysfunction is associated with an attenuated acute vascular response to inhaled prostanoid in pulmonary artery hypertension patients.  17:1012-1017. 2011
  • Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.  17:710-717. 2011
  • Hemodynamic factors associated with acute decompensated heart failure: Part 2 - Use in automated detection.  17:366-373. 2011
  • Hemodynamic factors associated with acute decompensated heart failure: Part 1 - Insights into pathophysiology.  17:282-291. 2011
  • CHAMPION trial rationale and design: The long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system.  17:3-10. 2011
  • Mast cell stabilization decreases cardiomyocyte and LV function in dogs with isolated mitral regurgitation.  16:769-776. 2010
  • Application of Implantable Hemodynamic Monitoring in the Management of Patients With Diastolic Heart Failure: A Subgroup Analysis of the COMPASS-HF Trial.  14:816-823. 2008
  • Factors Contributing to Global Cognitive Impairment in Heart Failure: Results From a Population-Based Cohort.  14:290-295. 2008
  • Incident Heart Failure Hospitalization and Subsequent Mortality in Chronic Heart Failure: A Propensity-Matched Study*.  14:211-218. 2008
  • Rationale, Design, and Methods for a Pivotal Randomized Clinical Trial of Continuous Aortic Flow Augmentation in Patients With Exacerbation of Heart Failure: The MOMENTUM Trial.  13:715-721. 2007
  • Clinical and analytical considerations in the study of health status in device trials for heart failure.  11:396-403. 2005
  • The impact of arrhythmias in acute heart failure.  10:279-284. 2004
  • Key issues in trial design for ventricular assist devices: A position statement of the Heart Failure Society of America.  10:91-100. 2004
  • Failure of benefit and early hazard of bucindolol for Class IV heart failure.  9:266-277. 2003
  • Felodipine improves left ventricular emptying in patients with chronic heart failure: V-HeFT III echocardiographic substudy of multicenter reproducibility and detecting functional change.  6:19-28. 2000
  • Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: The multicenter InSync randomized clinical evaluation (MIRACLE).  6:369-380. 2000
  • Effect of inotrope withdrawal on morbidity and mortality in patients with chronic heart failure: Results of the vesnarinone trial withdrawal substudy.  5:195-200. 1999
  • The relationship between cardiac function and neuropsychological status among heart transplant candidates.  4:295-303. 1998
  • International Standard Serial Number (issn)

  • 1071-9164
  • Electronic International Standard Serial Number (eissn)

  • 1532-8414